| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.008 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.009 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.01 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.01 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |